Published in Ann Surg on September 01, 2005
Commentary. Carotid stenting done exclusively by vascular surgeons. Perspect Vasc Surg Endovasc Ther (2006) 0.75
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet (2001) 5.82
Cerebral protection with filter devices during carotid artery stenting. Circulation (2001) 1.96
Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg (2004) 1.82
Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg (1998) 1.53
Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg (2004) 1.14
Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther (2003) 0.95
Carotid endarterectomy at the millennium: what interventional therapy must match. Ann Surg (2004) 0.91
Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg (2002) 0.87
Carotid endarterectomy remains the standard of care, even in high-risk surgical patients. Ann Surg (2005) 0.87
Intraluminal Palmaz stent implantation for treatment of recurrent carotid artery occlusive disease: a plan for the future. J Interv Cardiol (1995) 0.86
Carotid artery stenting: state of the art. J Interv Cardiol (2004) 0.86
Carotid artery stenting in octogenarians: is it too risky? Ann Vasc Surg (2005) 0.83
Another nail in the coffin of carotid endarterectomy. J Am Coll Cardiol (2001) 0.82
[Catheter dilatation of arteries supplying the brain]. Radiologe (1983) 0.82
Does carotid stenting measure up to endarterectomy? A vascular surgeon's experience. Arch Surg (2004) 0.81
History and current status of endovascular management for the extracranial carotid and supra-aortic vessels. J Endovasc Ther (2004) 0.81
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations. J Vasc Surg (2005) 0.81
Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA (2009) 6.11
Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med (2012) 4.62
Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg (2002) 3.35
The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med (2002) 3.32
Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med (2006) 2.73
Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg (2003) 2.71
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med (2008) 2.01
Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2007) 1.92
Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg (2010) 1.86
Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol (2008) 1.82
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg (2003) 1.74
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Ruptured abdominal aortic aneurysm after endovascular repair. J Vasc Surg (2002) 1.61
Internal endoconduit: an innovative technique to address unfavorable iliac artery anatomy encountered during thoracic endovascular aortic repair. J Vasc Surg (2008) 1.60
Critical limb ischemia. J Vasc Surg (2010) 1.58
Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, 1996-1999, with follow-up through 2004. J Vasc Surg (2009) 1.58
Emergent repair of acute thoracic aortic catastrophes: a comparative analysis. Arch Surg (2012) 1.58
Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg (2002) 1.57
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation (2003) 1.51
Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial. Am J Med (2011) 1.50
Bare metal stent infections: case report and review of the literature. J Vasc Surg (2007) 1.49
Five-year report of a multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysms. J Vasc Surg (2007) 1.48
Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J Vasc Surg (2008) 1.47
Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER trial. J Vasc Surg (2012) 1.42
The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex. J Surg Res (2011) 1.41
Tips and tricks for avoiding access problems when using large sheath endografts. J Vasc Surg (2009) 1.39
Utility of left subclavian artery revascularization in association with endoluminal repair of acute and chronic thoracic aortic pathology. J Vasc Surg (2006) 1.37
The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg (2007) 1.35
Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic Biol Med (2007) 1.30
Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. J Vasc Surg (2004) 1.29
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg (2002) 1.29
Early results with use of gracilis muscle flap coverage of infected groin wounds after vascular surgery. J Vasc Surg (2004) 1.26
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol (2003) 1.25
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation (2003) 1.22
Racial differences in primary and repeat lower extremity amputation: results from a multihospital study. J Vasc Surg (2005) 1.20
Explaining racial variation in lower extremity amputation: a 5-year retrospective claims data and medical record review at an urban teaching hospital. Arch Surg (2003) 1.20
Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc (2008) 1.20
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med (2002) 1.19
Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med (2003) 1.16
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc (2005) 1.16
A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv (2012) 1.15
Lower extremity nerve function in patients with lower extremity ischemia. Arch Intern Med (2006) 1.14
Percutaneous repair of abdominal aortic aneurysm. J Vasc Surg (2004) 1.13
Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. Am J Physiol Heart Circ Physiol (2008) 1.13
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12
Obesity, weight change, and functional decline in peripheral arterial disease. J Vasc Surg (2006) 1.12
Fate of excluded popliteal artery aneurysms. J Vasc Surg (2003) 1.10
Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol (2007) 1.09
Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg (2002) 1.09
Aneurysms of the carotid artery. Semin Vasc Surg (2005) 1.09
The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vasc Surg (2005) 1.08
Regarding "Race as a predictor of morbidity, mortality, and neurologic events after carotid endarterectomy". J Vasc Surg (2013) 1.07
Three-dimensional black-blood MR imaging of carotid arteries with segmented steady-state free precession: initial experience. Radiology (2007) 1.07
Abnormal joint powers before and after the onset of claudication symptoms. J Vasc Surg (2010) 1.06
Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease. J Vasc Surg (2008) 1.05
Prevention of thromboembolic events in surgical patients through the creation and implementation of a computerized risk assessment program. J Vasc Surg (2010) 1.04
Secondary infections of thoracic and abdominal aortic endografts. J Vasc Interv Radiol (2008) 1.02
Multislice dark-blood carotid artery wall imaging: a 1.5 T and 3.0 T comparison. J Magn Reson Imaging (2006) 1.01
A census-based analysis of racial disparities in lower extremity amputation rates in Northern Illinois, 1987-2004. J Vasc Surg (2008) 1.01
Contrast-enhanced MR angiography of the carotid and vertebrobasilar circulations. AJNR Am J Neuroradiol (2005) 1.01
Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation (2008) 1.00
Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. J Endovasc Ther (2009) 0.98
Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation? Ann Surg (2010) 0.98
Modified prosthetic vascular conduits. Circulation (2008) 0.98
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury. J Vasc Surg (2010) 0.97
Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide (2009) 0.97
Peripheral arterial disease in African Americans: clinical characteristics, leg symptoms, and lower extremity functioning. J Am Geriatr Soc (2004) 0.97
Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia. Nitric Oxide (2011) 0.96
Efficacy of a bifurcated endograft versus open repair of abdominal aortic aneurysms: a reappraisal. J Vasc Surg (2002) 0.96
Endovascular repair of blunt traumatic thoracic aortic injuries: seven-year single-center experience. Arch Surg (2010) 0.96
Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res (2005) 0.96
Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in abdominal aortic aneurysm repair. Circulation (2008) 0.96
Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery (2005) 0.95
Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes. Am J Physiol Heart Circ Physiol (2010) 0.95
Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status. Free Radic Biol Med (2011) 0.95
Sac behavior after aneurysm treatment with the Gore Excluder low-permeability aortic endoprosthesis: 12-month comparison to the original Excluder device. J Vasc Surg (2006) 0.94
Late abdominal aortic endograft explants: indications and outcomes. Surgery (2011) 0.94
Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem Biophys (2011) 0.94
Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2008) 0.94
Endovascular treatment of delayed type 1 and 3 endoleaks. Cardiovasc Intervent Radiol (2010) 0.94
Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med (2009) 0.94